Free Cash Flow per Share: A measure of financial performance calculated as operating cash flow minus capital expenditures, expressed on a per share basis. Calculated as: Free Cash Flow / Weighted Average Shares Outstanding (Diluted)
Qualigen Therapeutics, Inc. (QLGN) had Free Cash Flow per Share of $-10.46 for the most recently reported fiscal quarter, ending 2024-09-30.
| Income Statement Financials | |
-- |
|
$-1.82M |
|
-- |
|
-- |
|
$1.27M |
|
$-1.27M |
|
$-0.53M |
|
$-1.80M |
|
$-1.80M |
|
$-1.79M |
|
$-1.79M |
|
$-1.79M |
|
$-1.79M |
|
$-1.27M |
|
$-1.08M |
|
0.39M |
|
0.39M |
|
$-4.70 |
|
$-4.70 |
|
| Balance Sheet Financials | |
$2.31M |
|
-- |
|
-- |
|
$2.31M |
|
$4.45M |
|
-- |
|
-- |
|
$4.45M |
|
$-2.14M |
|
$-2.14M |
|
$-2.14M |
|
0.55M |
|
| Cash Flow Statement Financials | |
$-4.06M |
|
$-0.90M |
|
$4.94M |
|
$0.40M |
|
$0.39M |
|
$-0.01M |
|
$0.12M |
|
-- |
|
-- |
|
| Fundamental Metrics & Ratios | |
0.52 |
|
-- |
|
-- |
|
-- |
|
-0.67 |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
$-4.06M |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
-- |
|
83.80% |
|
83.80% |
|
-77.56% |
|
83.80% |
|
$-3.91 |
|
|
Free Cash Flow per Share |
$-10.46 |
$-10.46 |
|